Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/1995
07/19/1995EP0662833A1 Aqueous composition
07/19/1995EP0662831A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
07/19/1995EP0662826A1 Pharmaceutical compositions containing nonionic surfactants
07/19/1995EP0662823A1 Process for the preparation of drug pellets
07/19/1995EP0662819A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9- (2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof.
07/19/1995EP0662782A1 Pp14-based therapy
07/19/1995CN1105240A Pharmaceutical composition
07/18/1995US5434287 Bifunctional DTPA-type ligand
07/18/1995US5434242 Catalyst-free resorbable homopolymers and copolymers
07/18/1995US5434241 Biodegradable poly(lactic acid)s having improved physical properties and process for their preparation
07/18/1995US5434187 Adding an aliphatic dicarboxylic acid and a salt thereof to eye drops to extend dwell time of drops
07/18/1995US5434124 Herbicides
07/18/1995US5434076 Tumor-specific, cell surface-binding monoclonal antibodies
07/18/1995US5433959 Antisecretory agent such as lansoprazole stabilized by basic inorganic salts
07/18/1995US5433955 Site specific in vivo activation of therapeutic drugs
07/18/1995US5433950 Flexible collodion compositions
07/18/1995US5433946 Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases
07/18/1995CA2017801C Functionalized silicone oil aqueous dispersions curable into an elastomer by loss of water
07/18/1995CA1336323C Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base, with elimination, in solution, of the bitter taste, burning of the throat and intestinal toxicity
07/18/1995CA1336322C Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors
07/13/1995WO1995018636A2 Hepatocyte-targeted drug conjugates
07/13/1995WO1995018635A1 Low molecular weight hyaluronic acid with peptide or protein
07/13/1995WO1995018627A1 Method of making polymers having specific properties
07/13/1995WO1995018623A1 Oligomeric compounds having nitrogen-containing linkages
07/13/1995WO1995018603A1 Transdermal device containing polyvinylpyrrolidone as solubility enhancer
07/13/1995WO1995018598A1 Pharmaceutical ointment base
07/13/1995WO1995013095A3 Therapy
07/13/1995DE4400640A1 Diagnosis and treatment of malignant tumours
07/13/1995CA2181082A1 Oligomeric compounds having nitrogen-containing linkages
07/13/1995CA2180755A1 Pharmaceutical ointment base
07/13/1995CA2180348A1 Hepatocyte-targeted drug conjugates
07/12/1995EP0662513A1 Methods for preventing degradation of protein C
07/12/1995EP0662479A2 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses
07/12/1995EP0662322A2 Pharmaceutical composition for controlled release
07/12/1995EP0662321A1 Method for producing osmosis-controlled tablets avoiding the use of chlorinated hydrocarbons
07/12/1995EP0662320A1 Dry gel composition
07/12/1995EP0662319A1 Cosmetic and/or dermatologic composition for the treatment of aging containing ceramides, and its use
07/12/1995EP0662318A1 Cosmetic and/or dermatological composition containing salicylic acid derivatives and the solubilisation process of these derivatives
07/12/1995EP0662125A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes
07/12/1995EP0662002A1 Alginate-bioactive agent conjugates
07/12/1995EP0662000A1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
07/12/1995EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses
07/12/1995EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors
07/12/1995EP0661966A1 Ulcer prevention and treatment composition and method
07/12/1995EP0661924A1 Surface treatment composition.
07/12/1995EP0481042B1 Amphoteric hydrogel for medical devices
07/12/1995EP0215942B1 Polynucleotide assay reagent and method
07/12/1995CN1104896A Multifunction medicine for curing trauma
07/11/1995US5432196 Anipamil
07/11/1995US5432170 Fatty ester, nonionic surfactant
07/11/1995US5431916 Polyvinylpyrrolidone, triester
07/11/1995US5431914 Topical administration
07/11/1995US5431909 Stabilization of human interferon
07/11/1995US5431902 New medicament aerosol formulation based on fusafungine
07/11/1995CA2139018A1 Cosmetic and/or dermatologic composition for the treatment of aging comprising ceramids, and its use
07/11/1995CA2005143C Stabilized hydrophobic protein formulations of g-csf
07/11/1995CA1336308C Polysaccharide-protein conjugates
07/11/1995CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
07/06/1995WO1995018155A1 Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it
07/06/1995WO1995018136A1 Backbone modified oligonucleotide analogs and solid phase synthesis thereof
07/06/1995WO1995017953A1 High internal phase water/oil emulsions and water/oil/water emulsions
07/06/1995WO1995017909A1 Powdery pharmaceutical preparation and method of manufacturing same
07/06/1995WO1995017908A1 Method for selective methionine starvation of malignant cells in mammals
07/06/1995WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules
07/06/1995WO1995017901A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
07/06/1995WO1995017885A1 Inhibitors of urokinase plasminogen activator
07/06/1995WO1995017883A1 Water-in-oil lotion containing a corticosteroid
07/06/1995WO1995017882A1 Corticosteroid-containing w/o emulsion lotion
07/06/1995WO1995017831A1 Coprocessed galactomannan - glucomannan
07/06/1995CA2180335A1 High internal phase water/oil emulsions and water/oil/water emulsions
07/06/1995CA2180262A1 Method for selective methionine starvation of malignant cells in mammals
07/06/1995CA2180260A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
07/05/1995EP0661267A1 Chelating agent for attaching metal ions to proteins
07/05/1995EP0661061A2 Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment
07/05/1995EP0661060A2 Highly concentrated immunoglobulin composition and method to prepare it
07/05/1995EP0661052A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
07/05/1995EP0661047A1 Pharmaceutical formulation containing diphenhydramine, talc, calamine and oat extract in an emulsified base and uses thereof
07/05/1995EP0661045A1 Sustained-release hydrogel preparation
07/05/1995EP0661037A1 Composition against skinaging acting simultaneously on the superficial and deep skinlayers
07/05/1995EP0660723A1 Vp6 encapsulated drug delivery.
07/05/1995EP0660721A1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
07/05/1995EP0660717A1 Aminosteroids for ophthalmic use
07/05/1995EP0660714A1 Novel liposomal drug delivery systems
07/05/1995EP0660704A1 A process for producing suppositories by compression and suppositories obtained by the process.
07/05/1995EP0660702A1 Water-in-oil emulsions containing water-soluble alkyl glycosides
07/05/1995EP0660687A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
07/05/1995EP0660676A1 Novel compositions.
07/05/1995EP0660668A1 Iodine/resin disinfectant and a procedure for the preparation thereof
07/05/1995EP0493529B1 Yttrium and rare earth compounds catalyzed lactone polymerization
07/05/1995CN1104492A Anti-inflammatory analgesic plaster
07/05/1995CN1104488A Sustained releasable parenteral pharmaceutical preparations and method of producing the same
07/05/1995CN1104487A Pharmaceutical granulate
07/05/1995CA2112754A1 Returning malignant cells back to health
07/04/1995US5430116 Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals
07/04/1995US5430110 Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary
07/04/1995US5430057 Parenteral busulfan for treatment of malignant disease
07/04/1995US5430021 Hydrophobic drug delivery systems
07/04/1995US5430017 Oral pharmaceutical composition containing cyclosporin and process for preparing same
07/04/1995US5429836 Maltodextrin and emulsifier feed and matrix for foods
07/04/1995US5429824 Compound for diagnostic imaging a 4-(1,1,3,3-tetramethylbutyl) phenol polymer of ethylene oxide and formaldehyde